Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Vaccines for the elderly

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994 C. Ramière, L. Roche,

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C C. Sagnelli, M. Merli, C. Uberti-Foppa, H. Hasson,

Gut bacterial microbiota and obesity

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

I.J. Schalk Clinical Microbiology and Infection

D.A. Clark Clinical Microbiology and Infection

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

Virological tools to diagnose and monitor hepatitis C virus infection

Refugee crisis and re-emergence of forgotten infections in Europe

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Vector control: a cornerstone in the malaria elimination campaign

Unexpectedly high prevalence of Treponema pallidum infection in the oral cavity of human immunodeficiency virus-infected patients with early syphilis.

Training for the infectious diseases speciality in Norway

Isospora belli Clinical Microbiology and Infection

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Human infection with H9N2 avian influenza in northern China

Elements of design: the knowledge on which we build

Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences C.M. Olinger, N.V.

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Previously unknown species of Aspergillus

Pathogenesis of catheter-related infections: lessons for new designs

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Vaccinations against respiratory tract infections at Hajj

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Vaccines for the elderly

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

An after-hours clinical liaison blood culture service—is it worth it?

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Clinical Microbiology and Infection

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

J.L. Balcázar Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology and Infection Volume 24, Issue 4, Pages 440-441 (April 2018) DOI: 10.1016/j.cmi.2017.10.025 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Schematic representation of the GT-P genome. Direct-acting antiviral-target genes are underlined. Clinical Microbiology and Infection 2018 24, 440-441DOI: (10.1016/j.cmi.2017.10.025) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions